Published in Cardiovasc Res on May 01, 2002
Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation. Circulation (2009) 4.33
Increased vulnerability to atrial fibrillation in transgenic mice with selective atrial fibrosis caused by overexpression of TGF-beta1. Circ Res (2004) 3.30
Remodelling of gap junctions and connexin expression in diseased myocardium. Cardiovasc Res (2008) 2.43
Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease. Heart (2004) 2.23
Connexin gene transfer preserves conduction velocity and prevents atrial fibrillation. Circulation (2011) 2.16
Loss of mXinalpha, an intercalated disk protein, results in cardiac hypertrophy and cardiomyopathy with conduction defects. Am J Physiol Heart Circ Physiol (2007) 1.99
Atrial fibrillation ablation outcome is predicted by left atrial remodeling on MRI. Circ Arrhythm Electrophysiol (2013) 1.96
Atrial fibrosis and the mechanisms of atrial fibrillation. Heart Rhythm (2006) 1.86
Molecular determinants of cardiac fibroblast electrical function and therapeutic implications for atrial fibrillation. Cardiovasc Res (2010) 1.74
Cardiac magnetic resonance T1 mapping of left atrial myocardium. Heart Rhythm (2013) 1.73
Mechanism of origin of conduction disturbances in aging human atrial bundles: experimental and model study. Heart Rhythm (2006) 1.66
TRPM7-mediated Ca2+ signals confer fibrogenesis in human atrial fibrillation. Circ Res (2010) 1.65
Novel molecular targets for atrial fibrillation therapy. Nat Rev Drug Discov (2012) 1.42
Pirfenidone prevents the development of a vulnerable substrate for atrial fibrillation in a canine model of heart failure. Circulation (2006) 1.38
Atrial extracellular matrix remodelling in patients with atrial fibrillation. J Cell Mol Med (2008) 1.28
The role of fibroblasts in complex fractionated electrograms during persistent/permanent atrial fibrillation: implications for electrogram-based catheter ablation. Circ Res (2011) 1.27
K+ current changes account for the rate dependence of the action potential in the human atrial myocyte. Am J Physiol Heart Circ Physiol (2009) 1.17
Mechanistic inquiry into the role of tissue remodeling in fibrotic lesions in human atrial fibrillation. Biophys J (2013) 1.14
Methodology for patient-specific modeling of atrial fibrosis as a substrate for atrial fibrillation. J Electrocardiol (2012) 1.09
Atrial fibrillation in congestive heart failure. Heart Fail Clin (2010) 1.07
Connexin40 imparts conduction heterogeneity to atrial tissue. Circ Res (2008) 1.06
Electrophysiological remodeling in heart failure. J Mol Cell Cardiol (2010) 1.05
The fibrosis-cell death axis in heart failure. Heart Fail Rev (2016) 1.04
Improving cardiac gap junction communication as a new antiarrhythmic mechanism: the action of antiarrhythmic peptides. Naunyn Schmiedebergs Arch Pharmacol (2009) 1.03
Reduction and redistribution of gap and adherens junction proteins after ischemia and reperfusion. Ann Thorac Surg (2006) 1.02
Dysregulation of cell adhesion proteins and cardiac arrhythmogenesis. Clin Med Res (2006) 1.01
Determinants of myocardial conduction velocity: implications for arrhythmogenesis. Front Physiol (2013) 1.01
Mathematical approaches to understanding and imaging atrial fibrillation: significance for mechanisms and management. Circ Res (2014) 0.99
Atrial Fibrillation and Fibrosis: Beyond the Cardiomyocyte Centric View. Biomed Res Int (2015) 0.99
Atrial fibrillation therapy now and in the future: drugs, biologicals, and ablation. Circ Res (2014) 0.97
Triggers and anatomical substrates in the genesis and perpetuation of atrial fibrillation. Curr Cardiol Rev (2012) 0.95
Monogenic atrial fibrillation as pathophysiological paradigms. Cardiovasc Res (2010) 0.94
Is there a role for remodeled connexins in AF? No simple answers. J Mol Cell Cardiol (2007) 0.92
A simulation study of cellular hypertrophy and connexin lateralization in cardiac tissue. Biophys J (2010) 0.92
Remodeling of cardiac passive electrical properties and susceptibility to ventricular and atrial arrhythmias. Front Physiol (2014) 0.92
Increasing gap junctional coupling: a tool for dissecting the role of gap junctions. J Membr Biol (2007) 0.90
Atrial arrhythmogenicity in aged Scn5a+/DeltaKPQ mice modeling long QT type 3 syndrome and its relationship to Na+ channel expression and cardiac conduction. Pflugers Arch (2010) 0.89
Association of inflammation with atrial fibrillation in hyperthyroidism. J Geriatr Cardiol (2012) 0.88
Xin proteins and intercalated disc maturation, signaling and diseases. Front Biosci (Landmark Ed) (2012) 0.88
Structural contributions to fibrillatory rotors in a patient-derived computational model of the atria. Europace (2014) 0.88
Fibrosis in Atrial Fibrillation - Role of Reactive Species and MPO. Front Physiol (2012) 0.87
Novel association patterns of cardiac remodeling markers in patients with essential hypertension and atrial fibrillation. BMC Cardiovasc Disord (2011) 0.87
Association of left atrial function and left atrial enhancement in patients with atrial fibrillation: cardiac magnetic resonance study. Circ Cardiovasc Imaging (2015) 0.85
Expression of connexins 40 and 43 in human left atrium in atrial fibrillation of different aetiologies. Heart (2005) 0.85
Connexin40 abnormalities and atrial fibrillation in the human heart. J Mol Cell Cardiol (2014) 0.84
Effect of MR blockade on collagen formation and cardiovascular disease with a specific emphasis on heart failure. Heart Fail Rev (2005) 0.84
Transient receptor potential (TRP) channels and cardiac fibrosis. Curr Top Med Chem (2013) 0.84
Effect of spironolactone on patients with atrial fibrillation and structural heart disease. Clin Cardiol (2011) 0.83
Novel pharmacological targets for the rhythm control management of atrial fibrillation. Pharmacol Ther (2011) 0.83
Exploring susceptibility to atrial and ventricular arrhythmias resulting from remodeling of the passive electrical properties in the heart: a simulation approach. Front Physiol (2014) 0.83
[New antiarrhythmic drugs for therapy of atrial fibrillation: I. Ion channel blockers]. Herzschrittmacherther Elektrophysiol (2006) 0.83
Pitx2 modulates a Tbx5-dependent gene regulatory network to maintain atrial rhythm. Sci Transl Med (2016) 0.82
Left atrial pathological degeneration assessed by integrated backscatter transesophageal echocardiography as a predictor of progression to persistent atrial fibrillation: results from a prospective study of three-years follow-up. Cardiovasc Ultrasound (2012) 0.82
Role of caveolin-1 in atrial fibrillation as an anti-fibrotic signaling molecule in human atrial fibroblasts. PLoS One (2014) 0.82
Comparison of preexisting and ablation-induced late gadolinium enhancement on left atrial magnetic resonance imaging. Heart Rhythm (2014) 0.82
Atrial natriuretic peptide affects cardiac remodeling, function, heart failure, and survival in a mouse model of dilated cardiomyopathy. Hypertension (2013) 0.81
Functional abnormalities in iPSC-derived cardiomyocytes generated from CPVT1 and CPVT2 patients carrying ryanodine or calsequestrin mutations. J Cell Mol Med (2015) 0.81
Pleiotropic effects of statins in atrial fibrillation patients: the evidence. Vasc Health Risk Manag (2009) 0.80
Effects of metoprolol therapy on cardiac gap junction remodelling and conduction in human chronic atrial fibrillation. Br J Pharmacol (2011) 0.80
Fibrosis and electrophysiological characteristics of the atrial appendage in patients with atrial fibrillation and structural heart disease. J Interv Card Electrophysiol (2013) 0.80
Improved understanding of the pathophysiology of atrial fibrillation through the lens of discrete pathological pathways. Glob Cardiol Sci Pract (2014) 0.80
Clinical outcome of left atrial ablation for paroxysmal atrial fibrillation is related to the extent of radiofrequency ablation. J Interv Card Electrophysiol (2008) 0.79
Microscopic variations in interstitial and intracellular structure modulate the distribution of conduction delays and block in cardiac tissue with source-load mismatch. Europace (2012) 0.79
New insights into the roles of Xin repeat-containing proteins in cardiac development, function, and disease. Int Rev Cell Mol Biol (2014) 0.79
Roles of gap junctions and connexins in non-neoplastic pathological processes in which cell proliferation is involved. J Membr Biol (2007) 0.79
Inflammation and C-reactive protein in atrial fibrillation: cause or effect? Tex Heart Inst J (2014) 0.78
Accelerated fibrosis and apoptosis with ageing and in atrial fibrillation: Adaptive responses with maladaptive consequences. Exp Ther Med (2013) 0.78
Protein analysis of atrial fibrosis via label-free proteomics in chronic atrial fibrillation patients with mitral valve disease. PLoS One (2013) 0.78
A new role for extracellular Ca2+ in gap-junction remodeling: studies in humans and rats. Naunyn Schmiedebergs Arch Pharmacol (2008) 0.78
Increased expression of NF-AT3 and NF-AT4 in the atria correlates with procollagen I carboxyl terminal peptide and TGF-β1 levels in serum of patients with atrial fibrillation. BMC Cardiovasc Disord (2014) 0.78
An atrial-fibrillation-linked connexin40 mutant is retained in the endoplasmic reticulum and impairs the function of atrial gap-junction channels. Dis Model Mech (2014) 0.78
Pulmonary venous structural remodeling in a canine model of chronic atrial dilation due to mitral regurgitation. Can J Cardiol (2008) 0.77
Recent clinical and experimental advances in atrial fibrillation. ISRN Cardiol (2011) 0.77
Rapid automatic segmentation of abnormal tissue in late gadolinium enhancement cardiovascular magnetic resonance images for improved management of long-standing persistent atrial fibrillation. Biomed Eng Online (2015) 0.77
Myocardial sleeves of pulmonary veins and atrial fibrillation: a postmortem histopathological study of 100 subjects. Virchows Arch (2006) 0.77
Left atrial reverse remodeling and prevention of progression of atrial fibrillation with atrial resynchronization device therapy utilizing dual-site right atrial pacing in patients with atrial fibrillation refractory to antiarrhythmic drugs or catheter ablation. J Interv Card Electrophysiol (2014) 0.77
Association of Plasma Transforming Growth Factor-β1 Levels and the Risk of Atrial Fibrillation: A Meta-Analysis. PLoS One (2016) 0.76
Bioptic Study of Left and Right Atrial Interstitium in Cardiac Patients with and without Atrial Fibrillation: Interatrial but Not Rhythm-Based Differences. PLoS One (2015) 0.76
Results of complex left atrial ablation of long-lasting persistent atrial fibrillation. J Interv Card Electrophysiol (2008) 0.75
Molecular genetic analysis of six Dutch families with atrial fibrillation. Neth Heart J (2005) 0.75
Altered conductance and permeability of Cx40 mutations associated with atrial fibrillation. J Gen Physiol (2015) 0.75
Alterations in atrial perfusion during atrial fibrillation. Exp Physiol (2014) 0.75
Association of left atrial epicardial adipose tissue with electrogram bipolar voltage and fractionation: Electrophysiologic substrates for atrial fibrillation. Heart Rhythm (2016) 0.75
Progressive age-associated activation of JNK associates with conduction disruption in the aged atrium. Mech Ageing Dev (2015) 0.75
Role of the MAPKs/TGF-β1/TRAF6 signaling pathway in postoperative atrial fibrillation. PLoS One (2017) 0.75
Interatrial septal thickness as a marker of structural and functional remodeling of the left atrium in patients with atrial fibrillation. Korean J Intern Med (2015) 0.75
P-wave dispersion and its relationship with the severity of the disease in patients with stable coronary artery disease. North Clin Istanb (2014) 0.75
Lone AF: is There a Rationale? J Atr Fibrillation (2015) 0.75
Delayed gadolinium enhancement in the atrial wall: a novel finding in 3 patients with rheumatic heart disease. Tex Heart Inst J (2011) 0.75
Inflammatory cytokines and atrial fibrillation: current and prospective views. J Inflamm Res (2010) 0.75
Serine/Threonine Phosphatases in Atrial Fibrillation. J Mol Cell Cardiol (2017) 0.75
SR calcium handling dysfunction, stress-response signaling pathways, and atrial fibrillation. Front Physiol (2015) 0.75
Aliskiren protecting atrial structural remodeling from rapid atrial pacing in a canine model. Naunyn Schmiedebergs Arch Pharmacol (2016) 0.75
Potential Biological Markers of Atrial Fibrillation: A Chance to Prevent Cryptogenic Stroke. Biomed Res Int (2017) 0.75
Connexins in Cardiovascular and Neurovascular Health and Disease: Pharmacological Implications. Pharmacol Rev (2017) 0.75
The effects of polyunsaturated fatty acids and antioxidant vitamins on atrial oxidative stress, nitrotyrosine residues, and connexins following extracorporeal circulation in patients undergoing cardiac surgery. Mol Cell Biochem (2017) 0.75
Age-dependent electrical and morphological remodeling of the Drosophila heart caused by hERG/seizure mutations. PLoS Genet (2017) 0.75
The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy. Cell (2002) 4.72
Myocytes die by multiple mechanisms in failing human hearts. Circ Res (2003) 3.61
Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation (2003) 3.55
Bone marrow-derived cells contribute to infarct remodelling. Cardiovasc Res (2006) 2.00
Human hibernating myocardium is jeopardized by apoptotic and autophagic cell death. J Am Coll Cardiol (2004) 1.88
Oncostatin M is a major mediator of cardiomyocyte dedifferentiation and remodeling. Cell Stem Cell (2011) 1.72
Gap junctional remodeling by hypoxia in cultured neonatal rat ventricular myocytes. Cardiovasc Res (2005) 1.70
Gap junction remodeling and altered connexin43 expression in the failing human heart. Mol Cell Biochem (2003) 1.61
Laminin-alpha4 and integrin-linked kinase mutations cause human cardiomyopathy via simultaneous defects in cardiomyocytes and endothelial cells. Circulation (2007) 1.57
Connexin 43 expression and distribution in compensated and decompensated cardiac hypertrophy in patients with aortic stenosis. Cardiovasc Res (2004) 1.49
Fibrosis in endstage human heart failure: severe changes in collagen metabolism and MMP/TIMP profiles. Int J Cardiol (2010) 1.25
Giant molecule titin and myocardial stiffness. Circulation (2002) 1.17
The carboxyl-terminal region of ahnak provides a link between cardiac L-type Ca2+ channels and the actin-based cytoskeleton. FASEB J (2002) 1.16
A common MLP (muscle LIM protein) variant is associated with cardiomyopathy. Circ Res (2009) 1.11
Matrix metalloproteinases and their tissue inhibitors in pressure-overloaded human myocardium during heart failure progression. J Am Coll Cardiol (2004) 1.10
Remodeling of the vascular tunica media is essential for development of collateral vessels in the canine heart. Mol Cell Biochem (2004) 0.96
Mutation analysis of the transcription factor PU.1 in younger adults (16 to 60 years) with acute myeloid leukemia: a study of the AML Study Group Ulm (AMLSG ULM). Blood (2003) 0.96
Remodeling of the adventitia during coronary arteriogenesis. Am J Physiol Heart Circ Physiol (2002) 0.95
Mitral annuloplasty in patients with ischemic versus dilated cardiomyopathy. Eur J Cardiothorac Surg (2003) 0.94
Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice mimics ischemic preconditioning through SAPK/JNK1/2 activation. Cardiovasc Res (2003) 0.94
Expression of endothelial nitric oxide synthase in the vascular wall during arteriogenesis. Mol Cell Biochem (2004) 0.94
Expression profiling of cardiac genes in Tako-Tsubo cardiomyopathy: insight into a new cardiac entity. J Mol Cell Cardiol (2007) 0.93
Activation of the integrins alpha 5beta 1 and alpha v beta 3 and focal adhesion kinase (FAK) during arteriogenesis. Mol Cell Biochem (2008) 0.91
Ischemia depletes dystrophin and inhibits protein synthesis in the canine heart: mechanisms of myocardial ischemic injury. J Mol Cell Cardiol (2005) 0.90
Apoptosis in myocardial infarction. Ann Med (2002) 0.89
Regulation of EMAP II by hypoxia. Am J Pathol (2003) 0.88
Translocation and cleavage of myocardial dystrophin as a common pathway to advanced heart failure: a scheme for the progression of cardiac dysfunction. Proc Natl Acad Sci U S A (2004) 0.87
Pericardial hemangioma vascularized via left anterior descending. Clin Res Cardiol (2010) 0.86
Immunohistochemical study of the growth factors, aFGF, bFGF, PDGF-AB, VEGF-A and its receptor (Flk-1) during arteriogenesis. Mol Cell Biochem (2010) 0.86
Apoptosis: measurement and technical issues. J Mol Cell Cardiol (2004) 0.86
The carboxyl-terminal ahnak domain induces actin bundling and stabilizes muscle contraction. FASEB J (2004) 0.86
Structural remodelling in heart failure. Exp Clin Cardiol (2002) 0.85
Inflammatory aneurysm of the ascending thoracic aorta. J Thorac Cardiovasc Surg (2002) 0.85
Collateral vessel growth induced by femoral artery ligature is impaired by denervation. Mol Cell Biochem (2011) 0.84
Reduced sarcoplasmic reticulum Ca2+ -ATPase activity and dephosphorylated phospholamban contribute to contractile dysfunction in human hibernating myocardium. Mol Cell Biochem (2006) 0.84
Expression of cytoskeletal, linkage and extracellular proteins in failing dog myocardium. Heart Fail Rev (2005) 0.84
Deposition of nonsarcomeric alpha-actinin in cardiomyocytes from patients with dilated cardiomyopathy or chronic pressure overload. Exp Clin Cardiol (2009) 0.83
Morphological changes of the aortic valve leaflets in non-compliant aortic roots: in-vivo experiments. J Heart Valve Dis (2004) 0.83
Weakness of a giant: mutations of the sarcomeric protein titin. Trends Mol Med (2002) 0.82
Adult rat cardiac myocytes in culture: 'Second-floor' cells and coculture experiments. Exp Clin Cardiol (2006) 0.82
Porcine aortic endothelial cells show little effects on smooth muscle cells but are potent stimulators of cardiomyocyte growth. Mol Cell Biochem (2003) 0.81
Aneurysm formation after patch aortoplasty repair (Vossschulte): reoperation in adults with and without hypothermic circulatory arrest. Ann Thorac Surg (2002) 0.81
Predictors of failure to cure atrial fibrillation with the mini-maze operation. J Card Surg (2004) 0.81
TVP1022 attenuates cardiac remodeling and kidney dysfunction in experimental volume overload-induced congestive heart failure. Circ Heart Fail (2011) 0.80
Post-mitral valve repair systolic anterior motion produced by non-obstructive septal bulge. Eur J Cardiothorac Surg (2003) 0.80
Long-term follow-up after the mini-maze procedure. Ann Thorac Surg (2004) 0.80
Quantification of the cell-cycle inhibitors p27(Kip1) and p21(Cip1) in human atherectomy specimens: primary stenosis versus restenosis. J Lab Clin Med (2003) 0.79
Cell death and adenosine triphosphate: the paradox. Circulation (2005) 0.79
Presence of Cx37 and lack of desmin in smooth muscle cells are early markers for arteriogenesis. Mol Cell Biochem (2004) 0.79
Metabolic control analysis of anaerobic glycolysis in human hibernating myocardium replaces traditional concepts of flux control. FEBS Lett (2002) 0.78
mRNA cargo no longer on time. Am J Physiol Heart Circ Physiol (2008) 0.78
Increased glycolysis as protective adaptation of energy depleted, degenerating human hibernating myocardium. Mol Cell Biochem (2003) 0.78
Images in cardiovascular medicine. Natural tissue engineering inside a ventricular septum defect occluder. Circulation (2006) 0.77
Angiotensin-converting enzyme polymorphisms and their potential impact on left ventricular myocardial geometry after aortic valve surgery. J Heart Valve Dis (2003) 0.77
Changes in the preserved heart that limit the length of preservation. J Heart Lung Transplant (2002) 0.77
Transforming growth factor-beta1 downregulates beating frequency and remodeling of cultured rat adult cardiomyocytes. Cell Tissue Res (2005) 0.77
Effect of shunting of collateral flow into the venous system on arteriogenesis and angiogenesis in rabbit hind limb. Acta Histochem Cytochem (2013) 0.76
ANP expression in the hypertensive heart. Exp Clin Cardiol (2002) 0.75
The Formation of Aberrant Collateral Vessels during Coronary Arteriogenesis in Dog Heart. Cells Tissues Organs (2016) 0.75
Ferroelectric properties of composites containing BaTiO3 nanoparticles of various sizes. Nanotechnology (2014) 0.75
Carvedilol improves myocardial contractility compared with metoprolol in patients with chronic hibernating myocardium after revascularization. J Cardiovasc Pharmacol Ther (2005) 0.75